Dunhill Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.2K | Sell |
29
-8
| -22% | -$3.65K | ﹤0.01% | 402 |
|
|
2025
Q1 | $18.2K | Sell |
37
-5
| -12% | -$2.46K | 0.01% | 307 |
|
|
2024
Q4 | $17K | Sell |
42
-16
| -28% | -$6.47K | 0.01% | 296 |
|
|
2024
Q3 | $27.1K | Buy |
58
+24
| +71% | +$11.2K | 0.01% | 230 |
|
|
2024
Q2 | $15.7K | Buy |
34
+5
| +17% | +$2.32K | 0.01% | 240 |
|
|
2024
Q1 | $12.1K | Buy |
29
+3
| +12% | +$1.25K | 0.01% | 212 |
|
|
2023
Q4 | $10.6K | Buy |
+26
| New | +$10.6K | 0.01% | 201 |
|